Table 3.
Antimicrobial resistance of SA isolates in the infections and in colonization
| Antimicrobial | Wound infections [n = 14] no/% | Other infections [n = 2] no/% | Nasal swabs [n = 56] no/% | |||
|---|---|---|---|---|---|---|
| Erythromycin |
6 |
42.9 |
1 |
50.0 |
12 |
21.4 |
| Clindamycin |
5 |
35.7 |
1 |
50.0 |
7 |
12.5 |
| Norfloxacin |
11 |
78.6 |
2 |
100.0 |
30 |
53.6 |
| Ciprofloxacin |
11 |
78.6 |
2 |
100.0 |
30 |
53.6 |
| Gentamicin |
4 |
28.6 |
1 |
50.0 |
7 |
12.5 |
| Tobramycin |
9 |
64.3 |
2 |
100.0 |
28 |
50.0 |
| Amikacin |
9 |
64.3 |
2 |
100.0 |
28 |
50.0 |
| Mupirocin |
0 |
0.0 |
0 |
0 |
0 |
0.0 |
| Moxifloxacin |
11 |
78.6 |
2 |
100.0 |
26 |
46.4 |
| Methycillin* |
8 |
57.1 |
2 |
100.0 |
23 |
41.1 |
| Vancomycin** | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
*Resistance to methycillin was measured with PCR and therefore methycillin resistance means here mecA carriers.
**vancomycin resistance was measured with e-test.